Marion McCourt - Oct 3, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Commercial
Signature
/s/**Marion McCourt
Stock symbol
REGN
Transactions as of
Oct 3, 2022
Transactions value $
-$380,988
Form type
4
Date filed
10/5/2022, 04:11 PM
Previous filing
Sep 2, 2022
Next filing
Nov 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $223K +600 +3.05% $372.46 20.2K Oct 3, 2022 Direct F1
transaction REGN Common Stock Sale -$423K -600 -2.96% $705.39 19.6K Oct 3, 2022 Direct F1
transaction REGN Common Stock Options Exercise $171K +500 +2.55% $342.93 20.1K Oct 3, 2022 Direct F1
transaction REGN Common Stock Sale -$353K -500 -2.48% $705.39 19.6K Oct 3, 2022 Direct F1
holding REGN Common Stock 138 Oct 3, 2022 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -500 -100% $0.00* 0 Oct 3, 2022 Common Stock 500 $342.93 Direct F1, F2
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -600 -4.4% $0.00 13.1K Oct 3, 2022 Common Stock 600 $372.46 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.